Search results
Celldex Therapeutics Skids As It Takes On A Blockbuster Roche, Novartis Drug
Investor's Business Daily· 2 years agoCelldex Therapeutics took aim at Roche and Novartis' blockbuster hives treatment on Friday with a...
Why Celldex Therapeutics Blasted 13% Higher on Monday
Motley Fool· 8 months agoClinical-stage biotech Celldex Therapeutics (NASDAQ: CLDX) was a standout on the stock market...